Obstructive lung diseases and inhaler treatment: Results from a national public pragmatic survey

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Braido, Fulvio ^a   Baiardini, Ilaria ^a   Sumberesi, Massimo ^b   Blasi, Francesco ^c   Canonica, Giorgio W ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b DOXA Marketing Advice   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLERGY; ARTICLE; ASTHMA; ATTITUDE TO ILLNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; DEVICE SAFETY; FEMALE; HEALTH BELIEF; HEALTH SURVEY; HUMAN; INHALER; INTERVIEW; ITALY; MAJOR CLINICAL STUDY; MALE; POLLUTION; RELIABILITY; SMOKING; STRUCTURED QUESTIONNAIRE; AIR POLLUTANT; ARTIFICIAL VENTILATION; ATTITUDE TO HEALTH; HYPERSENSITIVITY; INHALATIONAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; NEBULIZER; PREVALENCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

BRONCHODILATING AGENT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIR POLLUTANTS; ASTHMA; ATTITUDE TO HEALTH; BRONCHODILATOR AGENTS; FEMALE; HEALTH SURVEYS; HUMANS; HYPERSENSITIVITY; ITALY; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RESPIRATORY THERAPY; SMOKING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884303724     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-94     Document Type: Article

References (32)

1. Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM. Economic burden of asthma: a systematic review. BMC Pulm Med. 2009, 19:9-24.
2. De Marco R, Cappa V, Accordini S, Rava M, Antonicelli L, Bortolami O, Braggion M, Bugiani M, Casali L, Cazzoletti L, Cerveri I, Fois AG, Girardi P, Locatelli F, Marcon A, Marinoni A, Panico MG, Pirina P, Villani S, Zanolin ME, Verlato G. GEIRD study group: trends in the prevalence of asthma and allergic rhinitis in italy between 1991 and 2010. Eur Respir J 2012, 39:883-892. 10.1183/09031936.00061611, 22005911.
3. Gershon A, Guan J, Victor JC, Wang C, To T. The course of asthma activity: a population study. J Allergy Clin Immunol 2012, 129:679-686. 10.1016/j.jaci.2011.11.014, 22178637.
4. World Health Organization Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach 2007, [Available from: http://www.who.int/gard/publications/GARD_Manual/en/index.html], World Health Organization.
5. http://www.who.int/gho/ncd/mortality_morbidity/en.
6. http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Causes_of_death_statistics/it.
7. http://www.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=1603&area=gard&menu=vuoto.
8. Dal Negro RW, Tognella S, Tosatto R, Dionisi M, Turco P, Donner CF. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes. Respir Med 2008, 102:92-101. 10.1016/j.rmed.2007.08.001, 17881206.
9. Dal Negro RW, Micheletto C, Tosatto R, Dionisi M, Turco P, Donner C. Costs of asthma in Italy: results of the SIRIO (Social Impact of Respiratory Integrated Outcomes) study. Respir Med 2007, 101:2511-2519. 10.1016/j.rmed.2007.07.011, 17822890.
10. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Available from: http://www.goldcopd.it/gruppi_lavoro/2011/GOLDPOCKETGUIDE2010.pdf], Global Initiative for Chronic Obstructive Lung Disease.
11. Global Initiative for Asthma Global strategy for asthma management and prevention 2011, [Available from: http://www.ginasthma.org/local/uploads/content/files/GINA_PubsReviewed_2011.pdf], Global Initiative for Asthma.
12. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf], Global Initiative for Chronic Obstructive Lung Disease.
13. Cutler DM, Everett W. Thinking outside the pillbox--medication adherence as a priority for health care reform. N Engl J Med 2010, 362:1553-1555. 10.1056/NEJMp1002305, 20375400.
14. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008, 63:831-838. 10.1136/thx.2007.086041, 18728206.
15. Howell G. Nonadherence to medical therapy in asthma: risk factors, barriers, and strategies for improving. J Asthma 2008, 45:723-729. 10.1080/02770900802395512, 18972285.
16. Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med 2009, 180:817-822. 10.1164/rccm.200902-0166OC, 19644048.
17. Baiardini I, Braido F, Giardini A, Majani G, Cacciola C, Rogaku A, Scordamaglia A, Canonica GW. Adherence to treatment: assessment of an unmet need in asthma. J Investig Allergol Clin Immunol 2006, 16:218-223.
18. Crompton GK, Barnes PJ, Broeders M, Corrigan C, Corbetta L, Dekhuijzen R, Dubus JC, Magnan A, Massone F, Sanchis J, Viejo JL, Voshaar T. Aerosol Drug Management Improvement Team: the need to improve inhalation technique in Europe: a report by the Aerosol Drug Management Improvement Team. Respir Med 2006, 100:1479-1494. 10.1016/j.rmed.2006.01.008, 16495040.
19. Brennan VK, Osman LM, Graham H, Critchlow A, Everard ML. Device compliance: the need to consider both competence and contrivance. Respir Med 2005, 99:97-102. 10.1016/j.rmed.2004.05.015, 15672856.
20. Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC, Jones PW. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009, 64:939-943. 10.1136/thx.2009.113662, 19703830.
21. Carls GS, Roebuck MC, Brennan TA, Slezak JA, Matlin OS, Gibson TB. Impact of medication adherence on absenteeism and short-term disability for five chronic diseases. J Occup Environ Med 2012, 54:792-805. 10.1097/JOM.0b013e31825463e9, 22796923.
22. Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, Dekhuijzen R, Sanchis J, Viejo JL, Barnes P, Corrigan C, Levy M, Crompton GK. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008, 102:593-604. 10.1016/j.rmed.2007.11.003, 18083019.
23. Soriano JB, Calle M, Montemayor T, Alvarez-Sala JL, Ruiz-Manzano J, Miravitlles M. The general public's knowledge of chronic obstructive pulmonary disease and its determinants: current situation and recent changes. Arch Bronconeumol 2012, 48:308-315.
24. Roche N, Perez T, Neukirch F, Carré P, Terrioux P, Pouchain D, Ostinelli J, Suret C, Meleze S, Huchon G. The gap between the high impact and low awareness of COPD in the population. Rev Mal Respir 2009, 26:521-529. 10.1016/S0761-8425(09)74671-6, 19543171.
25. Roche N, Perez T, Neukirch F, Carré P, Terrioux P, Pouchain D, Ostinelli J, Suret C, Meleze S, Huchon G. High prevalence of COPD symptoms in the general population contrasting with low awareness of the disease. Rev Mal Respir 2011, 28:58-65. 10.1016/j.rmr.2010.04.019, 21277475.
26. Miravitlles M, de la Roza C, Morera J, Montemayor T, Gobartt E, Martín A, Alvarez-Sala JL. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respir Med 2006, 100:1973-1980. 10.1016/j.rmed.2006.02.024, 16626950.
27. Evers U, Jones SC, Caputi P, Iverson D. The asthma knowledge and perceptions of older Australian adults: implications for social marketing campaigns. Patient Educ Couns 2013, 91:392-399. 10.1016/j.pec.2012.12.011, 23375546.
28. Grant EN, Turner-Roan K, Daugherty SR, Li T, Eckenfels E, Baier C, McDermott MF, Weiss KB. Development of a survey of asthma knowledge, attitudes, and perceptions: the Chicago Community Asthma Survey. Chicago Asthma Surveillance Initiative Project Team. Chest 1999, 116:178S-183S. 10.1378/chest.116.suppl_2.178S, 10532481.
29. Baiardini I, Braido F, Bonini M, Compalati E, Canonica GW. Why do doctors and patients not follow guidelines?. Curr Opin Allergy Clin Immunol 2009, 9:228-233. 10.1097/ACI.0b013e32832b4651, 19390434.
30. Laube BL, Janssens HM, De Jongh FH, Devadason SG, Dhand R, Diot P, Everard ML, Horvath I, Navalesi P, Voshaar T, Chrystyn H. European Respiratory Society; International Society for Aerosols in Medicine: what the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011, 37:1308-1331. 10.1183/09031936.00166410, 21310878.
31. Doyle S, Lloyd A, Williams A, Chrystyn H, Moffat M, Thomas M, Price D. What happens to patients who have their asthma device switched without their consent?. Prim Care Respir J 2010, 19:131-139. 10.4104/pcrj.2010.00009, 20174771.
32. Booker R. Do patients think that dry powder inhalers can be used interchangeably?. Int J Clin Pract Suppl 2005, 149:30-32.